Scientists along with an Indian origin scientist have learned that menopausal hormone therapy (MHT) will reduce the risk of heart failure. Menopausal hormone gets reduced as the ovaries age and start to realize low hormones. This affects the functions of FSH and LH which regulate the estrogen, progesterone, and testosterone.
The study shows the relation between menopausal hormone therapy and the change in structure and function of the heart. The survey which gets published in the journal PLOS ONE, state that the researchers observe the left ventricular (LV) and left atrial (LA) in 1604 post-menopausal women, who are at low or no risk of cardiovascular disease and 32 percent of women who had done MHT for three years.
The smaller LV and LA chamber were observed, and the outcomes of cardiovascular are favorable in which the mortality rate is low as well as the heart failure rate. The researchers also studied the LV mass which is one of the most critical parts of cardiovascular imaging. The increase in LV mass also increases the cardiovascular disease and mortality. On studying, they found no vast difference in LV mass between two groups of women.
They found that use of MHT does not affect the changes in cardiac structure and its functions.
The women whose age is under 60 and experiencing menopausal can get the benefit of HRT. As each, woman’s condition is different from each other, so it is advisable to refer experts before going for HRT as said by Sanghvi. The women who are thinking of getting HRT to make their heart health should avoid this. As the study does not cover all the effects which your cardiovascular experience while getting HRT said by the researchers.
